Try our Advanced Search for more refined results
May 04, 2011
Alza Corporation et al v. Impax Laboratories, Inc. et al
Case Number:
1:11-cv-00395
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 14, 2012
Impax Settles IP Row With J&J Over Generic Concerta
Impax Laboratories Inc. on Friday inked a deal with two Johnson & Johnson subsidiaries, giving Impax licensing rights to produce generic versions of the attention deficit hyperactivity disorder drug Concerta and putting to rest a lengthy patent infringement battle against the generic drugmaker.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login